https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-29 / Cancers (Basel) 2021 Nov;13(23)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-29 / Cancers (Basel) 2021 Nov;13(23)2021-11-29 00:00:002021-11-29 00:00:00The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-24 / World J Clin Oncol 2021 Nov;12(11):1064-1071
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-24 / World J Clin Oncol 2021 Nov;12(11):1064-10712021-11-24 00:00:002021-11-24 00:00:00Modulated electro-hyperthermia in stage III and IV pancreatic cancer: Results of an observational study on 158 patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-24 / World J Clin Oncol 2021 Nov;12(11):966-982
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-24 / World J Clin Oncol 2021 Nov;12(11):966-9822021-11-24 00:00:002023-03-22 14:41:40Modulation of the immune response by heterogeneous monocytes and dendritic cells in lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-19 / J Clin Transl Hepatol 2022 Apr;10(2):284-296
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-19 / J Clin Transl Hepatol 2022 Apr;10(2):284-2962021-11-19 00:00:002021-11-19 00:00:00Oncolytic Activity of Wild-type Newcastle Disease Virus HK84 Against Hepatocellular Carcinoma Associated with Activation of Type I Interferon Signaling
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-18 / Cancers (Basel) 2021 Nov;13(22)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-18 / Cancers (Basel) 2021 Nov;13(22)2021-11-18 00:00:002021-11-18 00:00:00A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-11 / Prostate 2021 Nov;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-11 / Prostate 2021 Nov;2021-11-11 00:00:002021-11-11 00:00:00Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-03 / Diseases 2021 Nov;9(4)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-03 / Diseases 2021 Nov;9(4)2021-11-03 00:00:002023-01-31 15:56:49Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients-A Single-Center Case-Control Study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-02 / Front Immunol 2021;12:770390
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-02 / Front Immunol 2021;12:7703902021-11-02 00:00:002021-11-02 00:00:00Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-02 / Cancers (Basel) 2021 Nov;13(21)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-02 / Cancers (Basel) 2021 Nov;13(21)2021-11-02 00:00:002023-03-22 14:41:41Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-01 / Clin Neuropharmacol 2021 Nov-Dec 01;44(6):216-221
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-01 / Clin Neuropharmacol 2021 Nov-Dec 01;44(6):216-2212021-11-01 00:00:002021-11-01 00:00:00The Efficacy of Dendritic Cell Vaccine for Newly Diagnosed Glioblastoma: A Meta-analysis of Randomized Controlled Studies
